136 related articles for article (PubMed ID: 23648436)
1. Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma.
Huo J; Du XL; Lairson DR; Chan W; Jiang J; Buchholz TA; Guadagnolo BA
Am J Clin Oncol; 2015 Jun; 38(3):235-41. PubMed ID: 23648436
[TBL] [Abstract][Full Text] [Related]
2. The rise of concurrent care for veterans with advanced cancer at the end of life.
Mor V; Joyce NR; Coté DL; Gidwani RA; Ersek M; Levy CR; Faricy-Anderson KE; Miller SC; Wagner TH; Kinosian BP; Lorenz KA; Shreve ST
Cancer; 2016 Mar; 122(5):782-90. PubMed ID: 26670795
[TBL] [Abstract][Full Text] [Related]
3. Meaningful changes in end-of-life care among patients with myeloma.
Odejide OO; Li L; Cronin AM; Murillo A; Richardson PG; Anderson KC; Abel GA
Haematologica; 2018 Aug; 103(8):1380-1389. PubMed ID: 29748440
[TBL] [Abstract][Full Text] [Related]
4. Survival and cost-effectiveness of hospice care for metastatic melanoma patients.
Huo J; Lairson DR; Du XL; Chan W; Buchholz TA; Guadagnolo BA
Am J Manag Care; 2014 May; 20(5):366-73. PubMed ID: 25181566
[TBL] [Abstract][Full Text] [Related]
5. Trends in end-of-life cancer care in the Medicare program.
Wang SY; Hall J; Pollack CE; Adelson K; Bradley EH; Long JB; Gross CP
J Geriatr Oncol; 2016 Mar; 7(2):116-25. PubMed ID: 26783015
[TBL] [Abstract][Full Text] [Related]
6. Variations in Hospice Utilization and Length of Stay for Medicare Patients With Melanoma.
Hutchinson RN; Lucas FL; Becker M; Wierman HR; Fairfield KM
J Pain Symptom Manage; 2018 Apr; 55(4):1165-1172.e5. PubMed ID: 29247755
[TBL] [Abstract][Full Text] [Related]
7. Hospital Case Volume Is Associated With Improved Survival for Patients With Metastatic Melanoma.
Huo J; Lairson DR; Du XL; Chan W; Jiang J; Buchholz TA; Guadagnolo BA
Am J Clin Oncol; 2016 Oct; 39(5):491-6. PubMed ID: 24755661
[TBL] [Abstract][Full Text] [Related]
8. Impact of Hospice on Spending and Utilization Among Patients With Lung Cancer in Medicare.
Kalidindi Y; Segel J; Jung J
Am J Hosp Palliat Care; 2020 Apr; 37(4):286-293. PubMed ID: 31564110
[TBL] [Abstract][Full Text] [Related]
9. End-of-life care in Medicare beneficiaries dying with pancreatic cancer.
Sheffield KM; Boyd CA; Benarroch-Gampel J; Kuo YF; Cooksley CD; Riall TS
Cancer; 2011 Nov; 117(21):5003-12. PubMed ID: 21495020
[TBL] [Abstract][Full Text] [Related]
10. Medicare Part D Use of Older Medicare Beneficiaries Admitted to Hospice.
Zueger PM; Holmes HM; Calip GS; Qato DM; Pickard AS; Lee TA
J Am Geriatr Soc; 2018 May; 66(5):937-944. PubMed ID: 29509282
[TBL] [Abstract][Full Text] [Related]
11. Racial and ethnic differences in end-of-life care in fee-for-service Medicare beneficiaries with advanced cancer.
Smith AK; Earle CC; McCarthy EP
J Am Geriatr Soc; 2009 Jan; 57(1):153-8. PubMed ID: 19054185
[TBL] [Abstract][Full Text] [Related]
12. Place of Death of Individuals with Terminal Cancer: New Insights from Medicare Hospice Place-of-Service Codes.
Jarosek SL; Shippee TP; Virnig BA
J Am Geriatr Soc; 2016 Sep; 64(9):1815-22. PubMed ID: 27534517
[TBL] [Abstract][Full Text] [Related]
13. Hospice use among Medicare managed care and fee-for-service patients dying with cancer.
McCarthy EP; Burns RB; Ngo-Metzger Q; Davis RB; Phillips RS
JAMA; 2003 May; 289(17):2238-45. PubMed ID: 12734135
[TBL] [Abstract][Full Text] [Related]
14. Association Between Hospice Length of Stay, Health Care Utilization, and Medicare Costs at the End of Life Among Patients Who Received Maintenance Hemodialysis.
Wachterman MW; Hailpern SM; Keating NL; Kurella Tamura M; O'Hare AM
JAMA Intern Med; 2018 Jun; 178(6):792-799. PubMed ID: 29710217
[TBL] [Abstract][Full Text] [Related]
15. End-of-life care for lung cancer patients in the United States and Ontario.
Warren JL; Barbera L; Bremner KE; Yabroff KR; Hoch JS; Barrett MJ; Luo J; Krahn MD
J Natl Cancer Inst; 2011 Jun; 103(11):853-62. PubMed ID: 21593012
[TBL] [Abstract][Full Text] [Related]
16. Intensity of Medical Interventions between Diagnosis and Death in Patients with Advanced Lung and Colorectal Cancer: A CanCORS Analysis.
Brooks GA; Cronin AM; Uno H; Schrag D; Keating NL; Mack JW
J Palliat Med; 2016 Jan; 19(1):42-50. PubMed ID: 26600474
[TBL] [Abstract][Full Text] [Related]
17. Comparison of SEER Treatment Data With Medicare Claims.
Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
[TBL] [Abstract][Full Text] [Related]
18. Associations Between End-of-Life Expenditures and Hospice Stay Length Vary by Clinical Condition and Expenditure Duration.
Hung P; Hsu SH; Wang SY
Value Health; 2020 Jun; 23(6):697-704. PubMed ID: 32540226
[TBL] [Abstract][Full Text] [Related]
19. Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009.
Teno JM; Gozalo PL; Bynum JP; Leland NE; Miller SC; Morden NE; Scupp T; Goodman DC; Mor V
JAMA; 2013 Feb; 309(5):470-7. PubMed ID: 23385273
[TBL] [Abstract][Full Text] [Related]
20. Delay of Surgery for Melanoma Among Medicare Beneficiaries.
Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP
JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
